Growth Metrics

Iridex (IRIX) Times Interest Earned (2012 - 2013)

Iridex's quarterly Times Interest Earned came in at $3.25 in Q4 2013, down 80.81% year-on-year from $16.94 in Q4 2012, and down 58.44% quarter-over-quarter from $7.82 in Q3 2013.

Iridex has reported Times Interest Earned for 2 years, with the latest figure at $3.25 in Q4 2013.

  • For the quarter ending Q4 2013, Times Interest Earned fell 80.81% year-over-year to $3.25; the trailing twelve-month figure through Sep 2014 stood at $12.63 (up 6.01% YoY), and the FY2013 full-year result was $7.1, up 273.3% from the prior year.
  • Times Interest Earned for Q4 2013 stood at $3.25, down from $7.82 in the prior quarter.
  • The five-year high for Times Interest Earned was $16.94 in Q4 2012, with the low at -$7.29 in Q2 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.73
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.32
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.09
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.23
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -2.90
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.36
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 20.98
10 Iridex 18.87 Mn 14.27 Mn 4.74 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 28, 2013 3.25
Sep 28, 2013 7.82
Jun 29, 2013 5.31
Dec 29, 2012 16.94
Sep 29, 2012 -4.95
Jun 30, 2012 -7.29